Kiyotoshi Imai
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.
Journal: Cancer science
Published: July 11, 2024
Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission.
Journal: Transplantation and cellular therapy
Published: September 20, 2021
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
Journal: International journal of hematology
Published: June 11, 2021
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
Journal: International journal of hematology
Published: August 25, 2020
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Journal: Annals of hematology
Published: August 05, 2018
Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 04, 2018
Treatment of relapsed or refractory acute lymphoblastic leukemia.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 06, 2017
Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.
Journal: Leukemia research
Published: August 16, 2017
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
Journal: International journal of hematology
Published: August 08, 2017
Acute lymphoblastic leukemia: pathophysiology and current therapy.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 09, 2017
Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.
Journal: International journal of hematology
Published: June 07, 2017
III.Acute Lymphoblastic Leukemia
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 25, 2017
Last Updated: 09/26/2026